FRIDAY, Sept. 23, 2022 (HealthDay News) — People with a rare genetic form of ALS may benefit from extended use of an investigational drug, a new study shows. The medication, tofersen, benefited patients with mutations of the gene SOD1. These mutations create a misfolded version of a protein, which leadsContinue Reading

THURSDAY, Sept. 22, 2022 (HealthDay News) — Climate change could spell trouble for those with heart failure, a new study suggests. When the temperatures soared in France during the summer of 2019, the heat wave appears to have worsened the conditions of heart failure patients, researchers report. “The finding isContinue Reading